BioSpace News Archive

Lotus Pharmaceutical, a multinational pharmaceutical company, reported its financial results for the third quarter ended 30 September 2022.

In a challenging market environment, the life science group Sartorius successfully placed Schuldschein loans with a volume of 650 million euros.

Sobi® will present new data at the 64th Annual Meeting of the American Society of Hematology taking place from 10 to 13 December 2022.

Cerevel Therapeutics announced that members of the management team will participate in three upcoming investor conferences.

Chemomab Therapeutics, Ltd today announced financial and operating results for the third quarter ended September 30, 2022 and provided a corporate update.

Tremeau Pharmaceuticals will present two abstracts highlighting a potential path forward for rofecoxib, the active ingredient in VIOXX, as a non-opioid treatment option during the American College of Rheumatology’s (ACR) Convergence Meeting in Philadelphia.

VBI Vaccines Inc. today announced that its abstract highlighting data from the ongoing Phase 2a study of VBI-1901, the Company’s cancer vaccine immunotherapeutic candidate in recurrent glioblastoma (GBM), was accepted for poster presentation at the 27th Annual Meeting and Education Day of the Society for Neuro-Oncology Annual Meeting.

Ur24Technology Inc., a privately held medical device company, has launched the TrueClr catheter product line.

Novocure (NASDAQ: NVCR) today announced receipt of CE Mark for its new polymer-based transducer array, called the flex array, designed for more efficient Tumor Treating Fields delivery and greater comfort for patients with glioblastoma.

Biomea Fusion, Inc. today announced that Biomea’s management will participate in a fireside chat and host investor meetings at the upcoming Piper Sandler 34th Annual Healthcare Conference.